logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > 1H-Indole-1-ethanol,5-aMino-2-[1,1-diMethyl-2-(phenylMethoxy)ethyl]-6-fluoro-α-[(phenylMethoxy)Methyl]-CAS 1294504-67-8

1H-Indole-1-ethanol,5-aMino-2-[1,1-diMethyl-2-(phenylMethoxy)ethyl]-6-fluoro-α-[(phenylMethoxy)Methyl]-CAS 1294504-67-8

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1294504-67-8

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
1294504-67-8
Appearance::
Very Dark Grey Solid
Molecular Formula::
C29H33FN2O3
Molecular Weight::
476.58200
EINECS NO::
NA
MDL NO::
MFCD23106326
CAS NO::
1294504-67-8
Appearance::
Very Dark Grey Solid
Molecular Formula::
C29H33FN2O3
Molecular Weight::
476.58200
EINECS NO::
NA
MDL NO::
MFCD23106326
1H-Indole-1-ethanol,5-aMino-2-[1,1-diMethyl-2-(phenylMethoxy)ethyl]-6-fluoro-α-[(phenylMethoxy)Methyl]-CAS 1294504-67-8

Product Description:

Product Name:

1H-Indole-1-ethanol,5-aMino-2-[1,1-diMethyl-2-(phenylMethoxy)ethyl]-6-fluoro-α-[(phenylMethoxy)Methyl]-, (αR)- CAS NO: 1294504-67-8

 

 

Synonyms:

(R)-1-(5-amino-2-(1-(benzyloxy)-2-methylpropan-2-yl)-6-fluoro-1H-indol-1-yl)-3-(benzyloxy)propan-2-ol;

(R)-( pound inverted question mark)-1-Benzyl-3-hydroxypiperidinol;

(-)-(3R)-1-benzylpiperidin-3-ol;

 

 

Chemical & Physical Properties:

Appearance: Very Dark Grey Solid

Assay :≥98.0%

Density: 1.16±0.1 g/cm3(Predicted)

Boiling Point: 648.5±55.0℃(Predicted)

 

 

Safety Information:

Signal Word: Warning

Hazard Statements: H315; H319; H335

Precautionary Statements: P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501

 

 

(R)-1-(5-Amino-2-(1-(benzyloxy)-2-methylpropan-2-yl)-6-fluoro-1H-indol-1-yl)-3-(benzyloxy)propan-2-ol is a Tezacaftor (T321510) intermediate. Tezacaftor is used as a combination therapy with Ivacaftor for the treatment of patients with cystic fibrosis.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.